Courthouse News Service  |  April 11, 2023

“If it stands, it would be open hunting season on FDA-approved drugs,” Lawrence Gostin, faculty director of the O’Neill Institute for National and Global Health Law and Georgetown Law, said in an email about Kacsmaryk’s injunction. “For example, red state governors or anti-vax groups could likely challenge the FDA’s authorization of COVID-19 vaccines, and that is just the tip of the iceberg. It sets the agency and the nation on a dangerous path.” 

Read more here.